These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 3527954
21. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment. Song DK, Zhao J, Zhang LR. J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368 [Abstract] [Full Text] [Related]
25. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation. Slapak M, Geoghegan T, Digard N, Ahmed K, Sharman VL, Crockett R. Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255 [No Abstract] [Full Text] [Related]
27. [Dermatologic problems in patients undergoing liver transplantation]. Reggiani M, Pauluzzi P, Bellusci R, De Raffele E, Nardo B, Gozzetti G. G Ital Dermatol Venereol; 1989 Sep; 124(9):393-6. PubMed ID: 2635141 [Abstract] [Full Text] [Related]
28. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. Tassaneeyakul W, Srimarthpirom S, Reungjui S, Chansung K, Romphruk A, Tassaneeyakul W. Transplantation; 2003 Jul 15; 76(1):265-6. PubMed ID: 12865824 [No Abstract] [Full Text] [Related]
29. Cataract in renal transplantation recipients with combination ciclosporin treatment. Nishimoto K, Sasaki K, Yamamura T, Ishikawa I, Shinoda A. Lens Eye Toxic Res; 1992 Jul 15; 9(3-4):455-67. PubMed ID: 1301797 [Abstract] [Full Text] [Related]
30. Dermatologic findings in renal transplant recipients: Possible effects of immunosuppression regimen and p53 mutations. Serdar ZA, Eren PA, Canbakan M, Turan K, Tellioglu G, Gülle S, Ozgezer T, Kara M, Berber I, Titiz MI. Transplant Proc; 2010 Sep 15; 42(7):2538-41. PubMed ID: 20832539 [Abstract] [Full Text] [Related]
33. Skin lesions treated with azathioprine and prednisone. Comparison of nontransplant patients and renal transplant recipients. Zimmerman SW, Esch J. Arch Intern Med; 1978 Jun 15; 138(6):912-4. PubMed ID: 148250 [Abstract] [Full Text] [Related]
34. [Drug-induced dermatological pathology in renal transplantation patients]. Tăranu T, Covic A, Buhăescu I, Tăranu T. Rev Med Chir Soc Med Nat Iasi; 2005 Jun 15; 109(1):36-9. PubMed ID: 16607824 [Abstract] [Full Text] [Related]
35. Multiple, large, polypoid infundibular (epidermoid) cysts in a cyclosporin-treated renal transplant recipient. Gupta S, Radotra BD, Kumar B, Pandhi R, Rai R. Dermatology; 2000 Jun 15; 201(1):78. PubMed ID: 10971072 [No Abstract] [Full Text] [Related]
36. Eruptive melanocytic naevi secondary to azathioprine: case report and review of the literature. Kravvas G, Kavanagh GM. Clin Exp Dermatol; 2018 Jan 15; 43(1):106-107. PubMed ID: 28994130 [No Abstract] [Full Text] [Related]
37. Tuberculosis and kidney transplantation. Riska H, Kuhlbäck B. Acta Med Scand; 1979 Jan 15; 205(7):637-40. PubMed ID: 382752 [Abstract] [Full Text] [Related]
38. Post-renal transplant azathioprine-induced pancreatitis. Siwach V, Bansal V, Kumar A, Rao Ch U, Sharma A, Minz M. Nephrol Dial Transplant; 1999 Oct 15; 14(10):2495-8. PubMed ID: 10528684 [No Abstract] [Full Text] [Related]